This inventor holds 1 USPTO granted patent. Top assignees: Glaxo Group Limited, King's College London, Vanderbilt University. Active years: 2019.
Company Filing History:
1 out of 1,169 
1 out of 196 
1 out of 1,220 
Years Active: 2019
Title: Jaques Pantel: Innovator in Melanocortin Receptor Modulation
Introduction
Jaques Pantel is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the development of positive allosteric modulators for the human melanocortin-4 receptor. His work has implications for various therapeutic applications.
Latest Patents
Jaques Pantel holds a patent for "Positive allosteric modulators of human melanocortin-4 receptor." This patent discloses positive allosteric modulators of the melanocortin receptor and methods for utilizing these modulators. His innovative approach has the potential to advance treatments related to metabolic disorders and obesity.
Career Highlights
Throughout his career, Pantel has been associated with prestigious institutions such as Vanderbilt University and King's College London. His work at these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
Some of his notable coworkers include Lawrence A. Wolfe and Julien A. Sebag. Their collaborative efforts have furthered research in the area of melanocortin receptors and their modulators.
Conclusion
Jaques Pantel's contributions to the field of biochemistry, particularly through his patent on melanocortin receptor modulators, highlight his role as an innovator. His work continues to influence research and potential therapeutic developments.